If you have been reading about CJC-1295 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Analog of growth hormone-releasing hormone |
| Chain length | 29 amino acids | Based on the GRF(1-29) fragment |
| Appearance | White to off-white lyophilized powder | Common research supply form |
| Solubility | Soluble in water and aqueous buffers | Powder requires reconstitution before use |
| Typical storage | −20 °C or below | Kept away from light and moisture |
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
The AAS that have been used most commonly in medicine are testosterone and its many esters (but most typically testosterone undecanoate, testosterone enanthate, testosterone cypionate, and testosterone propionate), nandrolone esters (typically nandrolone decanoate and nandrolone phenylpropionate), stanozolol, and metandienone (methandrostenolone). Others that have also been available and used commonly but to a lesser extent include methyltestosterone, oxandrolone, mesterolone, and oxymetholone, as well as drostanolone propionate (dromostanolone propionate), metenolone (methylandrostenolone) esters (specifically metenolone acetate and metenolone enanthate), and fluoxymesterone. Dihydrotestosterone (DHT), known as androstanolone or stanolone when used medically, and its esters are also notable, although they are not widely used in medicine. Boldenone undecylenate and trenbolone acetate are used in veterinary medicine. Designer steroids are AAS that have not been approved and marketed for medical use but have been distributed through the black market. Examples of notable designer steroids include 1-testosterone (dihydroboldenone), methasterone, trenbolone enanthate, desoxymethyltestosterone, tetrahydrogestrinone, and methylstenbolone.
(February 2, 2016), "Forensic Chemistry and Ambient Mass Spectrometry: A Perfect Couple Destined for a Happy Marriage?", Analytical Chemistry, 88 (5), American Chemical Society (ACS): 2515–2526, doi:10.1021/acs.analchem.5b02397, ISSN 0003-2700, PMID 26768158 Wu, Chunping; Dill, Allison L.; Eberlin, Livia S.; Cooks, R. Graham; Ifa, Demian R. (September 20, 2012), "Mass spectrometry imaging under ambient conditions", Mass Spectrometry Reviews, 32 (3), Wiley: 218–243, doi:10.1002/mas.21360, ISSN 0277-7037, PMC 3530640, PMID 22996621 Eberlin, Livia S.; Norton, Isaiah; Orringer, Daniel; Dunn, Ian F.; Liu, Xiaohui; Ide, Jennifer L.; Jarmusch, Alan K.; Ligon, Keith L.; Jolesz, Ferenc A.; Golby, Alexandra J.; Santagata, Sandro; Agar, Nathalie Y. R.; Cooks, R. Graham (January 8, 2013), "Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors", Proceedings of the National Academy of Sciences, 110 (5): 1611–1616, Bibcode:2013PNAS..110.1611E, doi:10.1073/pnas.1215687110, ISSN 0027-8424, PMC 3562800, PMID 23300285 Eberlin, Livia S.; Norton, Isaiah; Dill, Allison L.; Golby, Alexandra J.; Ligon, Keith L.; Santagata, Sandro; Cooks, R. Graham; Agar, Nathalie Y.R. (January 31, 2012), "Classifying Human Brain Tumors by Lipid Imaging with Mass Spectrometry", Cancer Research, 72 (3), American Association for Cancer Research (AACR): 645–654, doi:10.1158/0008-5472.can-11-2465, ISSN 0008-5472, PMC 3271168, PMID 22139378
A typical bicycle chain (for derailleur gears) uses narrow 1⁄2-inch-pitch chain. The width of the chain is variable, and does not affect the load capacity. The more sprockets at the rear wheel (historically 3–6, nowadays 7–12 sprockets), the narrower the chain. Chains are sold according to the number of speeds they are designed to work with, for example, "10 speed chain". Hub gear or single speed bicycles use 1/2 x 1/8 inch chains, where 1/8 inch refers to the maximum thickness of a sprocket that can be used with the chain. Typically chains with parallel shaped links have an even number of links, with each narrow link followed by a broad one. Chains built up with a uniform type of link, narrow at one and broad at the other end, can be made with an odd number of links, which can be an advantage to adapt to a special chainwheel-distance; on the other side such a chain tends to be not so strong. Roller chains made using ISO standard are sometimes called "isochains".
Sources: en.wikipedia.org
Therefore, techniques utilising relaxation measurements of carbon-13 and deuterium have recently been developed, which enables systematic studies of motions of the amino acid side-chains in proteins. A challenging and special case of study regarding dynamics and flexibility of peptides and full-length proteins is represented by disordered structures. Nowadays, it is an accepted concept that proteins can exhibit a more flexible behaviour known as disorder or lack of structure; however, it is possible to describe an ensemble of structures instead of a static picture representing a fully functional state of the protein. Many advances are represented in this field in particular in terms of new pulse sequences, technological improvement, and rigorous training of researchers in the field.
On December 31, 2020, Pritzker announced the expungement of approximately 500,000 non-felony cannabis-related arrest records. On February 22, 2021, Pritzker signed a criminal justice reform bill that, among other things, makes Illinois the first U.S. state to eliminate cash bail. The provision was scheduled to go into effect in January 2023, but was put on hold, pending the Illinois Supreme Court's review. In July 2023, the Illinois Supreme Court ruled that the elimination of cash bail was constitutional and would go into effect in September 2023.
Presidential Unit Citation (Army) for Sainte-Mère-Église. Presidential Unit Citation (Army) for Operation Market Garden. Presidential Unit Citation (Army) for Chiunzi Pass/Naples/Foggia awarded to the following units of the 82nd Airborne: 319th Glider Field Artillery Battalion, 307th Engineer Battalion (2nd), 80th Anti-aircraft Battalion and Company H, 504 PIR Presidential Unit Citation (Army) for the Battle of Samawah, April 2003, awarded to the following unit of the 82nd Airborne: 2nd Brigade Combat Team (325th Airborne Infantry Regiment) Presidential Unit Citation (Army) for Operation Turki Bowl, OIF, November 2007, awarded to the following unit of the 82nd Airborne: 5th Squadron, 73rd Cavalry, 3rd Brigade, 505th PIR Valorous Unit Citation (Army) for Operation Iraqi Freedom (3rd Brigade Combat Team, OIF 1) Valorous Unit Citation (Army) for actions on the objective in the Baghdad neighborhood of Ghazaliya. While attached to the 3rd Brigade, 1st Armored Division. Cited in Department of the Army General Order 2009–10 Meritorious Unit Commendation (Army) for Southwest Asia. Superior Unit Award (Army) US Army Garrison, Ft Bragg 11 September 2001 – 15 April 2006 Cited in DAGO 2009–29 French Croix de Guerre with Palm, World War II for Sainte-Mère-Église. French Croix de Guerre with Palm, World War II for Cotentin. French Croix de Guerre, World War II, Fourragère Belgian Fourragere 1940 Cited in the Order of the Day of the Belgian Army for action in the Ardennes Cited in the Order of the Day of the Belgian Army for action in Belgium And Germany.
The hospital specialized in the treatment of heart, lung and eye problems. UCC also provided a $2.2 million grant to Arizona State University to establish a vocational-technical centre in Bhopal, which was opened, but was later closed by the state government. They also donated $5 million to the Indian Red Cross after the disaster. They also developed a Responsible Care system with other members of the chemical industry as a response to the Bhopal crisis, which was designed to help prevent such an event in the future.
Sources: en.wikipedia.org
No. It is a laboratory-synthesized analog built on a fragment of the natural hormone. The natural peptide is shorter-lived and lacks the stabilizing substitutions found in the synthetic version.
DAC stands for drug affinity complex, a chemical group that binds the peptide to serum albumin. The binding slows clearance and lengthens the time the molecule stays in plasma compared with the unmodified analog.
Because two distinct molecules are discussed under one informal label. The albumin-binding version clears over several days, while the form without that group clears within roughly half an hour. Mixing results from both creates inconsistent figures.
Chromatography reports how much material elutes as a single peak but does not confirm what that material is. Mass spectrometry supplies the molecular mass, which is characteristic of a given sequence and its modifications. Together the two methods support both a purity figure and an identity claim.